Coronary Artery Calcification Risk Up With Gestational Diabetes
MONDAY, Feb. 1, 2021 -- Women with a history of gestational diabetes (GD) have an increased risk for coronary artery calcification (CAC) across all subsequent levels of glucose tolerance, according to a study published online Feb. 1 in Circulation.
Erica P. Gunderson, Ph.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues obtained data from a community-based cohort of young Black and White adults aged 18 to 30 years at baseline, including 1,133 women without diabetes at baseline (1985 to 1986) who had at least one singleton birth during follow-up. Participants underwent glucose tolerance testing at baseline and up to five times during 25 years of follow-up.
Overall, 12.3 percent of the 1,133 women reported GD. The researchers found that 25 percent of the women with GD and 15 percent of the women without GD had CAC. The adjusted hazard ratios (95 percent confidence intervals) were 1.54 (1.06 to 2.24) for no GD/prediabetes, 2.17 (1.30 to 3.62) for no GD/incident diabetes, 2.34 (1.34 to 4.09) for GD/normoglycemia, 2.13 (1.09 to 4.17) for GD/prediabetes, and 2.02 (0.98 to 4.19) for GD/incident diabetes (overall P = 0.003) compared with no GD/normoglycemia.
"Diabetes and other health problems that develop during pregnancy serve as early harbingers of future chronic disease risk, particularly heart disease," Gunderson said in a statement. "Health care systems need to integrate the individual's history of gestational diabetes into health records and monitor risk factors for heart disease."
One author disclosed financial ties to Janssen Pharmaceuticals.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
THURSDAY, March 4, 2021 -- Better maternal cardiovascular health (CVH) at 28 weeks of gestation is significantly associated with better offspring CVH at ages 10 to 14 years,...
TUESDAY, March 2, 2021 -- Birth weight modifies the association between adulthood levels of circulating insulin-like growth factor-1 (IGF-1) and development of type 2 diabetes...
FRIDAY, Feb. 26, 2021 -- From 2008 to 2017, the rates of recurrent myocardial infarction (MI), recurrent coronary heart disease (CHD) events, heart failure hospitalization, and...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.